Endothelin@25 – new agonists, antagonists, inhibitors and emerging research frontiers:<scp>IUPHAR R</scp>eview 12
Janet J. Maguire(University of Cambridge), Anthony P. Davenport(Addenbrooke's Hospital)
Cited by 59
Related Papers
International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands
|Pharmacological Reviews|2013|327
Advances in therapeutic peptides targeting G protein-coupled receptors
|Nature Reviews Drug Discovery|2020|270
Positron emission tomography using <sup>18</sup>F‐labelled endothelin‐1 reveals prevention of binding to cardiac receptors owing to tissue‐specific clearance by ET<sub>B</sub> receptors <i>in vivo</i>
|British Journal of Pharmacology|2004|65
A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertension
|British Journal of Pharmacology|2019|44
Evidence for biased agonists and antagonists at the endothelin receptors
|Life Sciences|2016|20